News & Updates

In Hong Kong, heart failure (HF) is a leading cause of hospitalization with a high readmission rate. Improved HF management models are needed to ensure continuous patient monitoring and rapid uptitration of guideline-directed medical therapy (GDMT). In an interview with MIMS Doctor, Dr Shun-Hei Wong, Specialist in Cardiology at Tseung Kwan O Hospital (TKOH), shared details of TKOH’s new HF management programme, which has notably reduced readmissions and improved functional capacity and other outcomes in patients with acute HF.

Results from the 10-year follow-up of the HOST-EXAM* trial favour clopidogrel over aspirin as chronic maintenance therapy after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES).

The conicity index (C-index) appears to be the most robust and most consistent prognostic value among adiposity indices in anticoagulated patients with atrial fibrillation (AF), suggests a study.

A 61-year-old female with a >20-year history of connective tissue disease–related pulmonary arterial hypertension (CTD-PAH) was admitted in June 2025. Despite being on triple therapy for PAH as well as prednisolone and cyclophospha­mide for systemic lupus erythematosus (SLE), her PAH remained uncontrolled. 

Researchers from the University of Hong Kong (HKU) have developed an innovative AI-based tool that can predict, with enhanced accuracy, the risk of six most common cardiovascular diseases (CVDs) up to 15 years prior to disease onset when combined with clinical data.

For adults with hypertension, maintaining a healthy lifestyle may help prevent the development of major cardiometabolic disease regardless of antihypertensive medication use, as shown in a study.

The uptake and optimization of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF) remain poor in Singapore, owing to underprescription, inadequate dosing, and medication discontinuation, according to a retrospective study.